Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators

被引:5
|
作者
Lemini, Riccardo [1 ]
Vico, Tamara Diaz [1 ]
Trumbull, Denslow A. [2 ]
Attwood, Kristopher [3 ]
Spaulding, Aaron C. [4 ]
Elli, Enrique F. [1 ]
Colibaseanu, Dorin T. [1 ]
Kukar, Moshim [5 ]
Gabriel, Emmanuel [1 ]
机构
[1] Mayo Clin, Dept Surg, Jacksonville, FL 32224 USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Roswell Park Comprehens Canc Ctr, Dept Biostat, Buffalo, NY USA
[4] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA
[5] Roswell Park Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA
关键词
Esophageal cancer; overall survival (OS); calculator; nomogram; neoadjuvant chemoradiation; BODY-MASS INDEX; NEOADJUVANT CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; PREDICTS SURVIVAL; COLON-CANCER; LYMPH-NODES; SURGERY; ADENOCARCINOMA; NOMOGRAM; CHEMORADIATION;
D O I
10.21037/jgo-20-337
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Determining the best approach for esophageal cancer and predicting accurate prognosis are critical. Multiple studies evaluated characteristics associated with overall survival, and several prediction models have been developed. This study aimed to evaluate existing models and perform external validation of selected models. Methods: A retrospective investigation of a multi-site institutional enterprise for patients with a diagnosis of esophageal cancer between 2013-2014 was performed. Selected survival prediction models included the Roswell Park Comprehensive Cancer Center (RPCCC) calculator, Oregon Health & Science University (OHSU) calculator, and two nomograms published by Shapiro et al. and Sun et al. One-year overall survival, level of agreement, and performance for each model were evaluated. Results: A total of 104 patients were included and used to assess the prediction models. One-year overall survival was 0.76. Different calculators tended to rank patients similarly; however, they did not agree on predicted overall survival. The least disparity in correlation was observed between OHSU and Shapiro calculators. Shapiro's model achieved the highest performance [area under the curve (AUC) =0.63]. Conclusions: Selected models showed fair results in estimating individual overall survival, although none achieved a high performance. While these tools may support the decision-making process for esophageal cancer patients, their implementation in clinical practice requires improved refinement to optimize their clinical utility.
引用
收藏
页码:1963 / 1972
页数:10
相关论文
共 50 条
  • [1] Research Prognostic evaluation of esophageal cancer patients with stages I-III
    Qiu, Meng-jun
    Yang, Sheng-li
    Wang, Meng-meng
    Li, Ya-nan
    Jiang, Xin
    Huang, Zao-zao
    Xiong, Zhi-fan
    AGING-US, 2020, 12 (14): : 14736 - 14753
  • [2] Surgical treatment experience for patients with stage I-III esophageal cancer
    Kolesnik, O. P.
    Kolesnyk, I. P.
    Kechedzhyiev, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2018, (03) : 448 - 453
  • [3] Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer
    Kamada, Teppei
    Furukawa, Kenei
    Takahashi, Junji
    Aida, Takashi
    Nakashima, Keigo
    Ito, Eisaku
    Suzuki, Norihiko
    Hata, Taigo
    Ohdaira, Hironori
    Eto, Ken
    Ikegami, Toru
    Suzuki, Yutaka
    ANTICANCER RESEARCH, 2024, 44 (08) : 3533 - 3541
  • [4] Prognostic and predictive value of radiomics signatures in stage I-III colon cancer
    Dai, Weixing
    Mo, Shaobo
    Han, Lingyu
    Xiang, Wenqiang
    Li, Menglei
    Wang, Renjie
    Tong, Tong
    Cai, Guoxiang
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (01): : 288 - 293
  • [5] The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer
    Li, Xiangde
    Zhong, Qiulu
    Luo, Danjing
    Du, Qinghua
    Liu, Wenqi
    PLOS ONE, 2019, 14 (04):
  • [6] A 10-gene prognostic methylation signature for stage I-III cervical cancer
    Cai, Shengyun
    Yu, Xiaomin
    Gu, Zhongyi
    Yang, Qingqing
    Wen, Biwei
    Sheng, Jizi
    Guan, Rui
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (05) : 1275 - 1287
  • [7] Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I-III colorectal cancer
    Xie, Hailun
    Wei, Lishuang
    Liu, Mingxiang
    Liang, Yanren
    Yuan, Guanghui
    Gao, Shunhui
    Wang, Qiwen
    Lin, Xin
    Tang, Shuangyi
    Gan, Jialiang
    BMC CANCER, 2022, 22 (01)
  • [8] Prognostic value of a modified Immunoscore in patients with stage I-III resectable colon cancer
    Zhao, Ke
    Wu, Xiaomei
    Li, Zhenhui
    Wang, Yingyi
    Xu, Zeyan
    Li, Yajun
    Wu, Lin
    Yao, Su
    Huang, Yanqi
    Liang, Changhong
    Liu, Zaiyi
    CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (03) : 379 - +
  • [9] Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer
    Takada, Akinori
    Nakamura, Tatsuya
    Takayama, Kanako
    Makita, Chiyoko
    Suzuki, Motohisa
    Azami, Yusuke
    Kato, Takahiro
    Tsukiyama, Iwao
    Hareyama, Masato
    Kikuchi, Yasuhiro
    Daimon, Takashi
    Toyomasu, Yutaka
    Ii, Noriko
    Nomoto, Yoshihito
    Sakuma, Hajime
    Fuwa, Nobukazu
    CANCER MEDICINE, 2016, 5 (03): : 506 - 515
  • [10] Survival comparison between postoperative and preoperative radiotherapy for stage I-III non-inflammatory breast cancer
    Zhang, Yuxi
    Xu, Zhipeng
    Chen, Hui
    Sun, Xinchen
    Zhang, Zhaoyue
    SCIENTIFIC REPORTS, 2022, 12 (01)